Newly developed reconstituted high-density lipoprotein containing sphingosine-1-phosphate induces endothelial tube formation
Introduction
High-density lipoproteins (HDL) are a heterogeneous group of small, dense lipoproteins. A low HDL level is one of the strongest predictors of coronary risk [1]. The negative correlation between coronary artery disease (CAD) and plasma HDL-cholesterol has been attributed to the ability of HDL to take up cellular cholesterol from the periphery and to mediate the transport of excess cholesterol to the liver [2].
HDL plays a crucial role in reverse-cholesterol transport [3]. A key factor in this process is the interaction between lipid depleted of apolipoproteinA–I (A–I) and the transmembrane protein ABCA1, which results in cellular cholesterol efflux. In addition, HDL has pleiotropic effects, in that it promotes anti-inflammation, including inhibition of the expression of adhesion molecules and monocyte chemotaxis, and anti-coagulation [4]. Although HDL is a target in the treatment of atherosclerotic CAD [5], there are currently only a limited number of therapeutic options to promote HDL. However, several exciting therapeutic strategies have recently been developed and are currently the focus of intense research such as the infusion of A–I [6], [7] or reconstituted(r)HDL, which may act as cholesterol acceptors [5]. rHDL that mimic the structure of A–I have anti-atherogenic effects in animal models [8], [9], [10]. A–I mimetic peptides have also been shown to inhibit inflammation [11] and thrombus formation [12]. In addition, Nissen et al. reported that 45 patients suffering from acute coronary syndrome received weekly infusions of A–I-Milano-phospholipid complexes over a period of 5 weeks. In patients who received the infusions, there was a significant regression in plaque size compared with baseline using intracoronary vascular ultrasound. Despite the small number of patients involved, this study has focused considerable attention on A–I-infusion as a therapeutic concept [13], and more attention has been paid to rHDL for the treatment of coronary atherosclerosis.
Sphingosine-1-phosphate (S1P), which is contained in HDL, is known to exhibit a wide variety of biological activities in many mammalian and other vertebrate cell types. S1P induces cell survival signaling and is involved in migration, proliferation, angiogenesis [14] and cytoskeletal changes in endothelial cells (ECs) mediated by a specific family of G protein-coupled (GPCRs) sphingosine 1-phosphate receptors [S1P1 (formerly endothelial differentiation gene-1 [Edg-1]), S1P2 (Edg-5), S1P3 (Edg-3), S1P4 (Edg-6) and S1P5 (Edg-8)] [15]. Therefore, we developed new rHDL, [(POPC(1-palmitoyl-2-oleoyl phosphatidylcholine)/S1P/A–I)]rHDL containing S1P. The new rHDL may induce cholesterol efflux and may have additional effects for cell survival, including proliferation and angiogenesis. In the future, the rHDL may be useful for the treatment of atherosclerotic cardiovascular disease, such as acute coronary syndrome and atherosclerosis obliterans.
Section snippets
Materials
The following antibodies and reagents were purchased: A–I (Calbiochem); PD98059, 2-(2′-amino-3′-methoxyphenyl) oxanaphthalen-4-one, a specific inhibitor of extracellular-signal-regulated kinases (ERK) (PD98059) (New England BioLabs); S1P and l-NAME (Nω-Nitro-l-arginine methyl ester hydrochloride) (Sigma); Akt inhibitor (1L-6-Hydroxymethyl-chio-inositol-2-(R)-2-O-methyl-3-O-octadecylcarbonate)(Merck); antibodies for Akt, phospho(p)-Akt, ERK1/2 and p-ERK1/2 (Thr202/Tyr204) (Cell Signaling
Characterization of discoidal rHDL
Characterization of discoidal rHDL by non-denaturing gradient gel electrophoresis showed that most of the (POPC/A–I)rHDL were 10.0 nm in diameter (Fig. 1). Minor populations of particles 10.7, 12.1. and 16.0 nm in diameter were also apparent in this preparation. The (POPC/S1P/A–I)rHDL particles were 9.8 nm in diameter. These rHDL particles did not contain discrete populations of larger particles. The absence of lipid-free apoA–I in the discoidal rHDL-containing tracks indicates that apoA–I was
Discussion
Previous studies have shown that rHDL has anti-atherosclerotic effects through the improvement of cholesterol efflux in addition to pleiotropic effects. In this study, we developed new rHDL and examined the mechanisms of their influence on these pleiotropic effects. We investigated the impact of ERK activation on new rHDL-mediated cell signaling and the induction of HCEC tube formation. Our results also identified ERK and Akt activation through S1P2 and S1P3 as a key player in HCEC tube
Study limitation
In this study, we assessed whether newly developed rHDL induced tube formation in an in vitro study. More detailed investigations for the clinical effects will be required to determine if rHDL induces the development of tube formation in vivo study because S1Ps may be diluted by other lipoproteins in plasma.
In summary, we have demonstrated a novel function of newly developed rHDL, in that HCEC tube formation was mediated by a ERK/Akt/NO pathway through S1P2 and S1P3 as well as enhanced
Acknowledgments
This work was supported by funds from the Central Research Institute of Fukuoka University, Japan. KAR is a Principal Research Fellow of the National Heart Foundation of Australia. We are grateful to Dr. K. Hirano (Osaka University) for providing cDNA of SR-BI.
References (38)
- et al.
Atheroprotective mechanisms of HDL
Atherosclerosis
(1999) - et al.
A new synthetic class A amphipathic peptide analogue protects mice from diet-induced atherosclerosis
J Lipid Res
(2001) - et al.
Ras/Raf1-dependent signal in sphingosine-1-phosphate-induced tube formation in human coronary artery endothelial cells
Biochem Biophys Res Comm
(2003) - et al.
Signaling of sphingosine-1-phosphate via the S1P/EDG-family of G-protein-coupled receptors
Biochim Biophys Acta
(2002) - et al.
Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate
Cell
(1999) - et al.
Changes in the size of reconstituted high density lipoproteins during incubation with cholesteryl ester transfer protein: the role of apolipoproteins
J Lipid Res
(1992) Delipidation of plasma lipoproteins
Meth Enzymol
(1986)Isolation and quantitation of apolipoproteins A–I and A–II from human high-density lipoproteins by fast-protein liquid chromatography
Clin Chim Acta
(1987)- et al.
Micellar complexes of human apolipoprotein A–I with phosphatidylcholines and cholesterol prepared from cholate-lipid dispersions
J Biol Chem
(1982) - et al.
Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1/KDR activation of c-Src
J Biol Chem
(1999)
Suppression of endothelial cell apoptosis by high density lipoproteins (HDL) and HDL-associated lysosphingolipids
J Biol Chem
Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability
Mol Cell
Sphingosine 1-phosphate protects human umbilical vein endothelial cells from serum-deprived apoptosis by nitric oxide production
J Biol Chem
Sphingosine 1-phosphate-induced cell proliferation, survival, and related signaling events mediated by G protein-coupled receptors Edg3 and Edg5
J Biol Chem
Sphingosine 1-phosphate in amniotic fluid modulates cyclooxygenase-2 expression in human amnion-derived WISH cells
J Biol Chem
Serum amyloid A binding to CLA-1 (CD36 and LIMPII analogous-1) mediates serum amyloid A protein-induced activation of ERK1/2 and p38 mitogen-activated protein kinases
J Biol Chem
Ras regulation of vascular endothelial growth factor and angiogenesis
Meth Enzymol
‘Accidental’ anti-angiogenic drugs: anti-oncogene directed signal transduction inhibitors and conventional chemotherapeutic agents as examples
Eur J Cancer
High-density lipoprotein—the clinical implications of recent studies
N Engl J Med
Cited by (27)
Dysfunctional high-density lipoproteins in coronary heart disease: implications for diagnostics and therapy
2016, Translational ResearchCitation Excerpt :Although present on only one of 10–20 HDL particles, S1P contributes to several of the protective functions of HDL. For example, HDL-associated S1P appears to be important for the vasoprotective effects on endothelial cell survival,104,105 endothelial migration,105 endothelial adhesion molecule expression,106,107 endothelial barrier integrity,23,108 endothelial tube formation,109 and nitric oxide–dependent vasorelaxation.20 It also inhibits vascular smooth muscle cell migration and chemokine production,31,110 cardiomyocyte apoptosis during hypoxia-reoxygenation,111,112 and myocardial damage after ischemia–reperfusion.112,113
Thematic review series: High density lipoprotein structure, function, and metabolism: Unraveling the complexities of the HDL lipidome
2013, Journal of Lipid ResearchCitation Excerpt :The S1P3 subclass of S1P receptors mediates stimulating effects of HDL on endothelial nitric oxide synthase (eNOS) (82, 83). The S1P2 and S1P3 subclasses participate in the activating effects of S1P on endothelial cell proliferation and tube formation mediated by Akt/ERK/NO (84). In addition, S1P2 and S1P3 receptors are involved in the stimulation of prostacyclin production by HDL-associated S1P, acting via upregulation of cyclooxygenase-2 in smooth muscle cells (85).
High-density lipoproteins: A consensus statement from the National Lipid Association
2013, Journal of Clinical LipidologyProtective roles of HDL, apoA-I and mimetic peptide on endothelial function: Through endothelial cells and endothelial progenitor cells
2009, International Journal of CardiologyCitation Excerpt :And the specific apoA-I mimetic peptide, 4F synthesized wholly from D-amino acids (D-4F), has been reported to improve HDL-mediated efflux and reverse cholesterol transport from macrophages, in conjunction with causing the formation of preβ HDL in apoE-null mice [10–11]. On the basis of recent findings, it is found that HDL has various direct effects on ECs [12]. However, relatively little is known about the effects of HDL on EPCs function.
Antiarrhythmogenic Effect of Reconstituted High-Density Lipoprotein Against Ischemia/Reperfusion in Rats
2008, Journal of the American College of CardiologyCitation Excerpt :However, rHDL may also interact directly with ABCA1 and ABCG1. Although newly developed pre-β-migrating discoidal HDL and mature HDL may interact with SR-BI (1) or sphingosine 1-phosphate 3 (29), these may not contribute to ERK activation in this study. The pathogenesis of I/R injury and arrhythmia involves many mechanisms (30).
High-density lipoprotein, sphingosine 1-phosphate, and atherosclerosis
2008, Journal of Clinical LipidologyCitation Excerpt :Currently, HDL-induced NO production in endothelial cells, inhibition of endothelial apoptosis, inhibition of expression of leukocyte adhesion–mediating molecules (ICAM-1, VCAM-1) in endothelial cells, and inhibition of growth factors–induced migration of smooth muscle cells may be firmly attributed to the lipoprotein S1P content.6,69–74 Most recent studies suggest that the ability of HDL to promote new vessel formation and other proangiogenic effects is also related to S1P.75 In each case, HDL appears to act as a functional partner for one of three S1P receptors: S1P1, S1P2, and/or S1P3.